Health Care & Life Sciences » Pharmaceuticals | Huaren Pharmaceutical Co. Ltd.

Huaren Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
857
907
1,093
1,227
1,286
1,356
Cost of Goods Sold (COGS) incl. D&A
421
500
649
732
657
631
Gross Income
436
408
443
495
629
725
SG&A Expense
262
293
342
395
506
648
EBIT
165
102
83
94
115
72
Unusual Expense
-
-
-
-
5
1
Non Operating Income/Expense
6
2
8
8
4
6
Interest Expense
24
40
61
60
53
40
Pretax Income
143
64
24
27
54
44
Income Tax
22
8
2
5
15
6
Consolidated Net Income
122
56
22
22
39
37
Net Income
122
56
23
24
38
39
Net Income After Extraordinaries
122
56
23
24
38
39
Net Income Available to Common
122
56
23
24
38
39
EPS (Basic)
0.11
0.05
0.02
0.02
0.03
0.03
Basic Shares Outstanding
1,121
1,158
1,145
1,136
1,132
1,151
EPS (Diluted)
0.11
0.05
0.02
0.02
0.03
0.03
Diluted Shares Outstanding
1,121
1,158
1,145
1,136
1,132
1,151
EBITDA
254
207
219
243
270
215
Other Operating Expense
9
12
19
6
9
5
Non-Operating Interest Income
2
1
1
1
1
7
Minority Interest Expense
-
-
1
2
2
1

About Huaren Pharmaceutical Co.

View Profile
Address
No. 187 Zhuzhou Road
Qingdao Shandong 266101
China
Employees -
Website http://www.qdhuaren.com
Updated 07/08/2019
Huaren Pharmaceutical Co., Ltd. engages in development, manufacture, and sale of non polyvinyl chloride and non-PVC large capacity preparations. Its products include basic, therapeutic, and nutritional infusion categories. The company was founded on August 23, 2001 and is headquartered in Qingdao, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.